Medication info
Megatelmisartan 40 mg (Telmisartan)

Megatelmisartan 40 mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
LNC Bio Co., Ltd.
Appearance
White oblong tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202000420 · Approved 2020.01.28 · Insurance code 060500520

Summary

Main use
Treatment of essential hypertension; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When increasing the dose, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine produces an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be administered orally once daily with water; it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive medicines may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
LNC Bio Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; prevention of cardiovascular diseases (myocardial infarction, stroke, etc.)

  • Essential hypertension
  • coronary artery disease
  • peripheral artery disease
  • stroke
  • transient ischemic attack
  • high-risk diabetes with clinical evidence of end-organ damage
View approved original text

This medication effectively controls blood pressure in patients with essential hypertension, helping to reduce the risk of cardiovascular diseases. It is particularly suitable for patients over 55 years of age who are at high risk for cardiovascular disease and cannot be given ACE inhibitors. These patients may include those with a history of coronary artery disease, peripheral artery disease, stroke, transient ischemic attack, or clinical evidence of end-organ damage in high-risk diabetes. This medication is used to reduce the risk of death from myocardial infarction, stroke, and cardiovascular diseases. Therefore, it contributes to improving cardiovascular health and preventing serious complications.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water and may be taken with or without food. A dose of 20 mg once daily may be effective in some patients. If necessary, the dose may be increased to 80 mg once daily. When increasing the dose, the maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment. This medicine produces an additional blood pressure-lowering effect when administered in combination with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be administered orally once daily with water; it may be taken with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive medicines may be required. ○ Patients with hepatic impairment Administer with caution to patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can pose serious risks to the fetus and neonates during pregnancy; therefore, it should be discontinued immediately if pregnancy is confirmed. Women who are pregnant or may become pregnant, as well as nursing mothers, should not use this medication. Patients with severely impaired liver function or issues with bile excretion should avoid this medication. Those with specific genetic disorders should also refrain from taking this drug. Elderly patients, patients with decreased kidney function, and patients with high serum potassium levels should use this medication with caution. Patients with heart disease or gastrointestinal disorders should also be cautious. During treatment with this medication, blood pressure, kidney function, and electrolyte levels should be monitored regularly. Serious side effects such as angioedema, hyperkalemia, and renal impairment may occur; consult a healthcare provider immediately if symptoms appear. Interactions may occur when combined with other antihypertensive drugs or specific medications, so it is essential to inform healthcare providers. This medication may cause symptoms such as hypotension, dizziness, and acute renal failure in the case of overdose; caution is advised. Safety and efficacy have not been established for children, so it is not recommended. Caution is required when driving or operating machinery due to the possibility of dizziness or fainting. Keep out of the reach of children and do not transfer the medication to another container.

Side effects

  • Upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 121 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual disturbances
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • shortness of breath
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal bloating
  • vomiting
  • abdominal discomfort
  • dry mouth
  • altered taste
  • liver function abnormalities
  • liver impairment
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • increased serum creatinine
  • increased serum uric acid
  • increased liver enzymes
  • elevated serum creatine kinase
  • decreased hemoglobin
  • hypoglycemia
  • fatigue
  • malaise
  • cold sweat
  • tremor
  • impaired concentration
  • convulsions
  • altered consciousness
  • angioedema
  • laryngeal edema
  • severe hyperkalemia
  • renal failure
  • shock
  • loss of consciousness
  • liver dysfunction
  • jaundice
  • respiratory distress
  • hypotension
  • laryngeal edema
  • interstitial pneumonia
  • fever
  • pneumonia
  • rhabdomyolysis
  • myalgia
  • elevated creatine kinase
  • increased myoglobin in blood and urine
  • palpitations
  • fatigue
  • nausea
  • inadequate effect
  • headache
  • dizziness
  • cough
  • dyspepsia
  • palpitations
  • arrhythmia
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • appetite loss
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial edema
  • rash
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechiae
  • headache
  • dizziness
  • myalgia
  • dermatitis
  • dizziness
  • dyspepsia
  • cough
  • abdominal pain
  • appetite loss
  • weakness
  • intestinal vascular edema
  • abdominal pain
  • nausea
  • vomiting
  • diarrhea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture. It is recommended to maintain a storage temperature between 1°C and 30°C. Proper storage helps to maintain the drug's effectiveness and safety.

Appearance and packaging

Appearance

White oblong tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.